Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 18:24:100325.
doi: 10.1016/j.metop.2024.100325. eCollection 2024 Dec.

Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India

Umasankari S  1 , S Aishwarya  1 , S K Aishwarya  1 , Shivangi Bhardwaj  1 , R B Pavithra  1 , Soumili Ray  1 , V M Vinodhini  1
Affiliations

Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India

Umasankari S et al. Metabol Open. .

Abstract

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 25 % of the global population, presenting a significant health challenge. It is often asymptomatic but linked to severe conditions like cirrhosis and liver cancer. Previous research indicates that people often underestimate MASLD risks. This study examines MASLD prevalence and awareness among medical students in an academic health care institute in India.

Material and methods: This cross-sectional study at SRM Medical College Hospital, Chennai, involved 80 medical and paramedical students aged 18-25. Exclusion criteria included history of alcohol use, neurological disorders, thyroid issues, diabetes, and hypertension. After obtaining informed consent, anthropometric data and blood samples were collected. Biochemical parameters including fasting plasma glucose, triglycerides, HDL-C, and GGT were measured. The Fatty Liver Index (FLI) was used to assess liver steatosis, with an FLI ≥60 indicating NAFLD. Data were analysed using SPSS Version 22.0, with statistical significance set at p < 0.05.

Results: Among 80 participants, the mean age and BMI were 20.2 ± 1.03 years and 23.16 ± 4.55 kg/m2. The mean Fatty Liver Index (FLI) score was 15.11 ± 19.68. MASLD prevalence was 7.5 % (n = 6). Significant positive correlations were found between FLI and BMI, waist circumference, fasting plasma glucose, triglycerides, and GGT, while HDL-C showed a non-significant negative correlation. Most participants were aware of MASLD and its risk factors but showed varied adherence to preventive measures.

Conclusion: Health Sciences undergraduates had a 7.5 % MASLD prevalence, highlighting a gap in understanding and testing. Addressing this requires better guidelines, awareness, and healthcare system enhancements.

Keywords: Fatty liver index; Metabolic dysfunction-associated steatotic liver disease and perception.

PubMed Disclaimer

Conflict of interest statement

Authors have no conflict of interest to disclose.

Figures

Fig. 1
Fig. 1
The prevalence of MASLD in study population.
See this image and copyright information in PMC

References

    1. Tomic D., Kemp W.W., Roberts S.K. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur J Gastroenterol Hepatol. 2018;30:1103–1115. doi: 10.1097/MEG.0000000000001235. - DOI - PubMed
    1. Goh George B.B., Kwan Clarence, Ying Lim Sze, Venkatanarasimha Nanda KK., Abu-Bakar Rafidah, Krishnamoorthy Thinesh L., Shim Hang Hock, Tay Kiang Hiong, Chow Wan Cheng. Perceptions of non-alcoholic fatty liver disease – an Asian community-based study. Gastroenterology Report. May 2016;4(2):131–135. - PMC - PubMed
    1. Khang A.R., Lee H.W., Yi D., Kang Y.H., Son S.M. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. Diabetes Metab Syndr Obes. 2019 Jan 24;12:181–190. - PMC - PubMed
    1. Muthiah M.D., Sanyal A.J. Burden of disease due to nonalcoholic fatty liver disease. Gastroenterol Clin N Am. 2020;49:1–23. doi: 10.1016/j.gtc.2019.09.007. - DOI - PubMed
    1. Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed

LinkOut - more resources